Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia

Andrea Caporali, Marco Meloni, Ashley M Miller, Klemens Vierlinger, Alessandro Cardinali, Gaia Spinetti, Audrey Nailor, Ezio Faglia, Sergio Losa, Ambra Gotti, Orazio Fortunato, Tijana Mitic, Manuela Hofner, Christa Noehammer, Paolo Madeddu, Costanza Emanueli

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

The p75 neurotrophin receptor (p75(NTR)) contributes to diabetes mellitus-induced defective postischemic neovascularization. The interleukin-33 receptor ST2 is expressed as transmembrane (ST2L) and soluble (sST2) isoforms. Here, we studied the following: (1) the impact of p75(NTR) in the healing of ischemic and diabetic calf wounds; (2) the link between p75(NTR) and ST2; and (3) circulating sST2 levels in critical limb ischemia (CLI) patients.
Original languageEnglish
Pages (from-to)e149-60
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume32
Issue number12
DOIs
Publication statusPublished - Dec 2012

Keywords / Materials (for Non-textual outputs)

  • Activating Transcription Factor 2
  • Aged
  • Aged, 80 and over
  • Animals
  • Biological Markers
  • Cells, Cultured
  • Diabetes Complications
  • Diabetes Mellitus
  • Diabetes Mellitus, Experimental
  • Disease Models, Animal
  • Endothelium, Vascular
  • Female
  • Humans
  • Ischemia
  • Lower Extremity
  • Male
  • Mice
  • Mice, Knockout
  • Middle Aged
  • Nerve Tissue Proteins
  • Predictive Value of Tests
  • Receptors, Cell Surface
  • Receptors, Interleukin
  • Receptors, Nerve Growth Factor
  • Streptozocin
  • Wound Healing
  • p38 Mitogen-Activated Protein Kinases

Fingerprint

Dive into the research topics of 'Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia'. Together they form a unique fingerprint.

Cite this